Latest information on COVID-19
TOGETHER WE CAN STOP THE SPREAD
Everything you need to know about COVID-19 in one place. Find out what help is available and get the latest updates.
Call your GP before you visit. Or call the Coronavirus Health Information Line on 1800 020 080
Check whether you have symptoms - Healthdirect online symptom checker
ON THIS PAGE
- LATEST UPDATES FROM THE FEDERAL DEPARTMENT OF HEALTH
- LATEST AMA NEWS
- AMA COVID-19 FACT FILES
- AMA COVID-19 FACT SHEETS
- FREQUENTLY ASKED QUESTIONS - GENERAL
- FREQUENTLY ASKED QUESTIONS - DOCTORS
The Department of Heath website provides up to date information for health professionals and patients on the evolving COVID-19 situation.
Check their website for:
AMA POSITION STATEMENTS
- AMA Federal Council - COVID-19 Communique
- AMA advocacy to support Doctors in Training during the COVID-19 response
- AMA Position Statement on Ethical Considerations for Medical Practitioner in Disaster Response 2008. Revised 2014
MEDIA STATEMENTS AND TRANSCRIPTS
- Dr Tony Bartone - Sunrise - Flu shot - 2 APRIL
- Government's JobKeeper Support Package will keep Medical Practices Operating - 31 MARCH
- Dr Tony Bartone - Today Show - COVID-19, PPE Masks, Private Hospitals - 30 MARCH
- Dr Tony Bartone - Doorstop - Telehealth announcement - 29 MARCH
- COVID-19 - AMA and Government Develop Improved Telehealth Arrangements for Patients - 29 MARCH
- Freeing up Public Hospitals to cope with COVID-19 - 28 MARCH
- The Health of Aboriginal and Torres Strait Islander People Must be a Priority in COVID-19 Response - 27 MARCH
- Dr Tony Bartone - ABC AM - Coronavirus, school closures - 26 MARCH
- COVID-19 is Challenging the Capacity of our Nation: Letter to all doctors from AMA President Dr Tony Bartone - 25 MARCH
- Dr Tony Bartone - Today Show - Telehealth and COVID-19 - 24 MARCH
- Expanded Telehealth Vital to Containing Covid-19 and Protecting Doctors and their Patients - 23 MARCH
- Dr Tony Bartone - Sunrise - COVID-19 testing kits - 19 MARCH
- Dr Chris Zappala - Sky News - Coronavirus - 18 MARCH
- Dr Tony Bartone - COVID-19 and school closures - 17 MARCH
- AMA Federal Council - COVID-19 is a national public health emergency - 14 MARCH
- COVID-19: A National Public Health Emergency - 13 MARCH
- Dr Tony Bartone - Doorstop - Coronavirus Response Package - 11 MARCH
- Dr Tony Bartone - RN Breakfast - Coronavirus - 11 MARCH
- COVID-19 Package Welcome but Much More To Do - 11 MARCH
- Dr Tony Bartone - 3AW - Frontline health workers and coronavirus - 8 MARCH
- Dr Chris Zappala - Sunrise - Coronavirus - 6 MARCH
- Dr Tony Bartone - ABC Radio - Coronavirus - 4 MARCH
- Dr Bartone - ABC News Breakfast - Coronavirus - 2 MARCH
- Dr Tony Bartone - ABC Radio - Coronavirus - 2 MARCH
- Dr Tony Bartone - Today - Coronavirus - 11 FEBRUARY
- Dr Tony Bartone - 3AW - Hospital wait times in Victoria - 6 FEBRUARY
- Dr Bartone - Sky News - Coronavirus - 31 JANUARY
- Dr Tony Bartone - Doorstop - Evacuation of Australians from China - 30 JANUARY
- Dr Tony Bartone - Today - Coronavirus and Christmas Island - 30 JANUARY
- Coronavirus Screening Informed by Previous Virus Responses - 30 JANUARY
- Dr Tony Bartone - Sunrise - Coronavirus - 29 JANUARY
- Dr Tony Bartone - Sky News - Coronavirus - 28 JANUARY
- Dr Tony Bartone - Coronavirus - 24 JANUARY
Throughout the COVID-19 crisis, the AMA will publish The COVID-19 Fact Files – clinical articles from the frontline of health care, dealing with the issues at the core of keeping Australians healthy while the nation works together through the pandemic. The articles will be evidence-based and reflect the reality of life for doctors working daily to help all Australians survive and maintain their health in the time of COVID-19.
|AMA Vice President Dr Chris Zappala||COVID-19 Transmission and Personal Protective Equipment (PPE)|
Download the latest AMA Fact Sheets on COVID-19
- COVID-19 Daily Fact sheet - latest case numbers and Government updates
- COVID-19 General Information - what it is, how it is transmitted, social distancing, vulnerable populations
- COVID-19 - personal hygiene tips
- COVID-19 - what to do if you are unwell
- COVID-19 - Tobacco-use and COVID-19
- COVID-19 - Medicines - New*
- COVID-19 School closures - New*
For more information call the Coronavirus Health Information Line on 1800 020 080
- WHAT IS COVID-19?
- HOW DOES COVID-19 SPREAD?
- WHAT ARE THE SYMPTOMS OF COVID-19?
- WHEN IS TESTING FOR COVID-19 REQUIRED
- WHO SHOULD GET TESTED?
- HOW DO I PROTECT MYSELF AND OTHERS?
- WHAT SHOULD I DO IF I'M VULNERABLE?
- I'M PREGNANT WHAT DO I NEED TO DO?
- SHOULD I STAY AT HOME?
- WHEN SHOULD I SEEK MEDICAL ATTENTION?
- WHAT DO I DO IF I'M DIAGNOSED WITH COVID-19?
Are you a doctor and have questions about COVID-19? Contact the AMA
- WHAT ARE THE NEW TELEHEALTH MBS ITEMS AND WHO CAN USE THEM?
- WHY ARE ONLY SOME ITEMS AVAILABLE UNDER THE COVID-19 TELEHEALTH ITEMS?
- CAN I TRIAGE ALL PATIENTS WHO CALL WITH COVID-19 SYMPTOMS?
- WHAT IS THE NEW PRACTICE INCENTIVE PAYMENT FOR GENERAL PRACTICES?
- WHAT ARE THE BULK BILLING INCENTIVES THAT HAVE BEEN DOUBLED?
- THE MBS ITEMS I USE ARE NOT AVAILABLE OR HAVE IMPRACTICAL RULES ASSOCIATED - WHAT CAN I DO?
- CAN I CHARGE A GAP FEE WITH THESE TELEHEALTH ITEMS?
- DO I NEED TO BE LOCATED IN MY PRACTICE TO PROVIDE TELEHEALTH SERVICES?
- DO I NEED MY PATIENTS SIGNATURE FOR PROVIDING A TELEHEALTH SERVICE?
- CAN A PATIENT ASIGN A BENEFIT WITHOUT A PHYSICAL SIGNATURE IF THEY COME INTO THE PRACTICE?
- HOW DO I PROVIDE A SCRIPT OR MAKE A REFERRAL FROM A TELEHEALTH SERVICE?
- CAN MY PRACTICE STAFF PROVIDE COVID-19 TELEHEALTH SERVICES?
- WHICH NEW TELEHEALTH MBS ITEMS CAN BE CLAIMED FOR TELEHEALTH SERVICES TO RACF PATIENTS?
- I'M HAVING DIFFICULTY SECURING PPE OR OTHER CONSUMABLES WHAT SHOULD I DO?
- WHAT IS THE MECHANISM FOR THE PATIENT TO ASSIGN THEIR BENEFIT TO THE PRACTITIONER FOR BULK BILLED TELEHEALTH OR TELEPHONE SERVICES?
- AM I COVERED BY MY MEDICAL INDEMNITY INSURANCE FOR MY COVID-19 TELEHEALTH ITEMS?
- WHAT SUPPORT IS AVAILABLE FOR MEDICAL PRACTICES DURING COVID-19 OUTBREAK?
- MY PATIENT HAS ASKED IF THEY CAN GET A PRESCRIPTION THAT ENABLES THEM TO STOCKPILE THEIR MEDICATION – WHAT SHOULD I DO?
- WHAT ARE THE NEW PHARMACY SALE AND DISPENSING LIMITS?
- WHAT ARE THE RESTRICTIONS ON HYDROXYCHLOROQUINE?
- IS THE PBS AUTHORITIES LINE NO LONGER ACTIVE, OR BROKEN?
- I'M A DOCTOR AND I WANT TO HELP OUT - WHERE CAN I GO TO OFFER MY SERVICES?
- WHAT IS THE MEDICAL BOARD DOING IN RESPONSE TO THE COVID-19 PANDEMIC FOR CPD, INTERNS AND IMGs?
- IS THE MEDICAL BOARD LIKELY TO ANNOUNCE FURTHER CHANGES?
- I AM A RECENTLY RETIRED DOCTOR CAN I RETURN TO PRACTICE?
- Coronavirus Health Information Line 1800 020 080
- Federal Department of Health and Chief Medical Officer - Media Contact: 0466 533 960/02 6289 7400
- Latest Global Case Numbers - John Hopkins University COVID-19 Tracker
- Travel Advice from the Australian Government
- Healthdirect 1800 022 222
AUSTRALIAN CAPITAL TERRITORY
NEW SOUTH WALES
COVID-19 is an infectious disease caused by the coronavirus SARS-CoV-2. COVID-19 first originated in humans after being transmitted from animals and can now be transmitted from human-to-human via droplets.
Like the flu, COVID-19 can be transmitted from person to person. The scientific evidence confirms that COVID-19 is spread by droplets.
- droplets being transmitted directly from an infected person to the mucous membranes (eyes, mouth, nose) of an uninfected person; or
- droplets being transmitted from the respiratory system of an infected person onto an external surface and subsequently picked up by an uninfected person and transferred to their mucous membranes (usually when they touch their face). The virus can survive on external surfaces for approximately 48 hours at room temperature.
The incubation period (the time between exposure to the virus and the appearance of symptoms) is estimated at between 2 to 14 days.
Once infected, the symptoms of COVID-19 can appear very similar to a common cold, but also extend to severe and sometimes fatal respiratory disease.
The most common symptoms are fever and a dry cough, and additional symptoms may include muscle aches, runny or stuffy nose, sore throat, shortness of breath, and in some cases breathing difficulties.
To date, approximately 80% of people with COVID-19 will only develop a mild infection, 14% will require routine hospitalisation, and 6-8% will require intensive care. It is important to understand that these are early numbers based on acute cases, and likely miss many asymptomatic infections.
Check if you have symptoms - Healthdirect has an online symptom checker
Due to a global shortage of COVID-19 test kits, the current advice from the Australian Government is that tests for COVID-19 should be restricted to people who have developed symptoms within 14 days of having contact with a confirmed case, or within 14 days of arriving in Australia from overseas; healthcare workers who work directly with patients and develop respiratory illness and fever; and people with community-acquired pneumonia with no clear cause.
People presenting for COVID-19 testing should inform the medical facility before arriving, and provide clear and accurate information about their symptoms, travel history and recent contacts.
- anyone who develops a fever or acute respiratory infection AND:
- has arrived in Australia from overseas within 14 days of developing symptoms; or
- has been in close contact with a person who has been diagnosed with COVID-19 within 14 days of developing symptoms; or
- is a health worker working directly with patients; or
- has severe community-acquired pneumonia with no clear cause.
- Who are health workers or aged/residential care worker; or
- Live in a geographically isolated area with an elevated risk of transmission; or
- Live in aged and residential care, a rural and remote Aboriginal and Torres Strait Islander community; a detention or correctional facility, a boarding school or a military base; or
- Have been hospitalised with an unknown cause of symptoms.
- Victoria is also testing anyone with fever or acute respiratory infection who is also Aboriginal or Torres Strait Islander.
- SOCIAL DISTANCING
- SOCIAL ISOLATION
Practising good hand and general hygiene is one of the most effective methods of slowing the spread of COVID-19. This includes washing hands frequently before and after eating; after going to the bathroom; and after returning home. Appropriate handwashing should take at least 20 seconds and involve washing all surfaces on the hands. Commonly missed areas include fingertips, thumbs, in between fingers, and the back of hands. Coughs and sneezes should be covered with a tissue or elbow, and tissues disposed of immediately.
Hands should be washed with soap and water or alcohol-based hand sanitiser after blowing the nose or touching the face.
Regularly washing your hands with soap and water is one of the most effective ways to prevent the spread of disease. If running water is not available, alcohol-based hand sanitiser is a good alternative, but will only be effective if your hands are not visibly dirty. Washing your hands should take at least 20 seconds - don't forget to scrub your fingertips, between your fingers and the backs of your hands as well as your palms. More detailed advice on handwashing technique is available from Health Direct here
- ￼Surgical Masks
For uninfected people, wearing a surgical mask in public is unlikely to significantly reduce your risk of being infected with COVID-19. Healthy people do not need to wear surgical masks in public. However, people who have been diagnosed with COVID-19, as well as those that come into close contact with them and those with suspected cases, should wear surgical masks when they interact with others and in public spaces. More detailed advice on surgical masks is available from the Australian Department of Health here.
- Touching your face
Avoiding touching your face is an important way to slow the spread of COVID-19. The infection can be spread when you pick up virus-containing droplets from an external surface with your hands, and then transfer them onto your mucous membranes (eyes, nose and mouth). Unfortunately, touching your face is a very common human instinct, and often a reaction to stress - so it can be hard to stop completely. Tactics to reduce face-touching include folding your hands in your lap, wearing gloves, and even post-it reminders. Healthline has produced a handy article on how to avoid touching your face here
Other handy tips:
- Avoid handshakes, hugging and kissing as greetings;
- Cover sneezes and coughs with a tissue or the crook of your elbow;
- Dispose of tissues immediately after using them;
- Clean commonly-touched surfaces (door handles, desks, benches, keyboards) daily; and
- Stay at home if you are sick.
Social distancing is a proven method of stopping or slowing the spread of COVID-19 and involves reducing contact between people in both public and private spaces. Social distancing has proven a simple, powerful and effective tactic to slow the transmission of COVID-19. Useful social distancing measures include:
- cancelling public events and large family gatherings;
- reducing visits to public spaces like restaurants, libraries and shopping centres, and
- working from home or not attending workplaces where possible.
When people do interact in public and private spaces, maintaining physical distance between each other can also make it harder for the virus to spread. Current advice from the Australian Government recommends maintaining a distance of at least 1.5 metres where possible. Avoiding handshakes or kissing as a form of greeting others is another important way to reduce physical contact.
Wearing a mask in public is unlikely to reduce your risk of being infected, but is recommended for those in close contact with confirmed or suspected cases.
Social isolation occurs when people who are infected with COVID-19 or suspected of being infected with COVID-19, limit their contact with other people as much as possible. Currently, some people with mild cases of COVID-19, and those with suspected cases, are self-isolating at home or in other confined environments. Close contacts of confirmed cases, as well as people who have arrived in Australia from overseas, are required to quarantine themselves at home. Quarantine differs from self-isolation in that it is a precautionary measure taken by people who are currently healthy.
People who are required and able to self-isolate are advised to use private transport to travel to their isolation location, and cannot leave to visit public places other than a health facility. The Australian Government has produced detailed guidance for self-isolation, which can be accessed here.
Several groups of Australians are at a higher risk than the general population of being infected with COVID-19, and a higher risk than the general population of developing severe symptoms once infected.
The following people should take extra precautions against becoming infected, including staying at home if possible:
- Older Australians: starting at age 60, there is an increasing risk of disease, and this risk increases with age. The highest risk of serious illness and death is in people older than 80.
- People with compromised immune systems and/or existing chronic health conditions: these existing conditions, like diabetes, heart disease, lung disease, and autoimmune conditions, can make it harder for people's immune systems to fight the virus.
- Aboriginal and Torres Strait Islander peoples are at a higher risk because of the higher rate of chronic conditions in these populations.
- People living in group residential settings such as detention facilities and aged care facilities, where infections can spread quickly.
Additional measures that you can take include:
- If you are immune-compromised, avoid staying with a person who is self-isolating (because they are a close contact of a confirmed case of COVID-19 or have recently travelled to any country except those listed in the countries and areas of concern.)
- You should stay at least 2 metres away from people who are unwell if you are immune-compromised.
- It's also important that everyone helps to protect the safety of immunocompromised people living in our community. For example, if you’re unwell, avoid contact with someone who is immune-compromised.
- At this time, it wouldn’t make sense for someone who is immune-compromised to wear a mask when in public to decrease the risk of catching COVID-19. However, if your health care provider advises you to wear a mask when in public areas because you have a particularly vulnerable immune system, follow that advice.
- If you are taking immunosuppressive drugs, we advise that you do not stop this medication without first consulting your GP or specialist.
Detailed information about the impact of COVID-19 on pregnant women and their babies is yet to be determined. Pregnant women are at risk of more severe symptoms from the flu, but thus far do not appear to be at higher risk than the general population of severe COVID-19 symptoms. RANZCOG has prepared detailed advice for pregnant women, which can be accessed here.
If you don't meet the criteria for COVID-19 testing, but have symptoms of sickness or feel unwell, you should still stay at home and limit your contact with others. Your doctor can provide you with further advice. If you do meet the criteria for COVID-19 testing, you should self-isolate at home until you can attend a health facility to be tested, and remain self-isolated until you receive your test results.
Those who have come into close contact with a person who has been diagnosed with COVID-19, MUST quarantine themselves at home for 14 days after their most recent contact with that person. More advice on close contacts and quarantine is available from the Department of Health.
- have been diagnosed with COVID-19 virus but are not a patient of a hospital; OR
- are isolating yourself in quarantine in accordance with home isolation guidance issued by the Australian Health Protection Principal Committee; OR
- are more susceptible to the COVID-19 virus because you are at least 70 years old; at least 50 years old or over if of Aboriginal or Torres Strait Islander descent; pregnant; a parent of a child under 12 months; or a person under treatment for chronic health conditions or who is immune-compromised; OR
- Meet the current national testing criteria for suspected COVID-19 infection.
If you get a positive test result and are diagnosed with COVID-19, follow the advice of your medical practitioner and local public health unit. You may need to be admitted to hospital, and you will need to provide detailed information about your recent movements and contacts. For some people with mild infections, it may be possible to self-isolate at home.
The Australian Government has produced detailed advice for self-isolating, including how to care for someone diagnosed with COVID-19, here
Temporary MBS telehealth and phone consultation items were introduced on 13 March in response to the COVID-19 outbreak. These items allow doctors to deliver services via videoconference and phone to patients to reduce the risk of transmission of COVID-19. The Government has determined that these items can only be bulk billed.
The telehealth item descriptors largely mirror those of existing face to face consultation items (equivalent items can be found in a table here). The items for telehealth and telephone services have been generalised and expanded since they were first introduced on 13 March.
These services can now be provided to all Medicare-eligible Australians who are not admitted to hospital.
A telehealth service must only be provided where it is safe and clinically appropriate to do so.
The bulk billing incentive has been doubled to better support the bulk billing of General Practice, Diagnostic Imaging and Pathology Services.
While the Government is encouraging practitioners to utilise telehealth where it is appropriate and feasible to do so, it also expects that practitioners have in place arrangements to ensure that patients can access face to face consultation where it is clinically required. This does not necessarily have to be with the same practitioner – it can also be with another practitioner working in the practice.
Where a provider needs to conduct telehealth consultations from their home, they should also use their provider number for their primary location.
The new temporary MBS telehealth items will have similar requirements to the normal items on which they are based. For example, where an item is usually provided by a patients usual GP, such as a GP Management Plan, the replicant telehealth or telephone item would also need to be provided by the patient’s usual GP.
The new temporary MBS telehealth items have similar requirements to the normal items on which they are based. For example where an item is usually provided by a patients usual GP, such as a GP Management Plan, the replicant telehealth or telephone item should also be provided by the patient’s usual GP.
For information on patient eligibility criteria and regular updates go to MBS online here.
The AMA has argued strongly that the Government should open up the MBS to allow telehealth to be used for a broad range of consultation items. The AMA welcomes the efforts of the Government to expand the GP telehealth items for COVID-19. The AMA is consulting with the Government on the process of expanding the available items for non-GP specialists.
The AMA will continue to speak directly to the Government and the Department of Health, highlighting issues with the current arrangements as they emerge and working towards broader telehealth access for consultation items for non-GP specialists.
Yes. Now that you can see all patients, you may triage all patients. There are still limited testing requirements in place. These criteria are updated regularly and may vary from state to state.
The Government is temporarily doubling the next two Practice Incentive Program (PIP) Quality Improvement (QI) Incentive for general practices. This means that practices will receive $10 per SWPE to a maximum quarterly value of $25,000. These payments will be made on 1 May and 1 August.
To qualify for this, practices must provide face-to-face services for a minimum of four hours a day, or for 50 per cent of normal practice opening hours for part-time practices. This increase is to encourage practices to continue to provide face to face services.
More details are available in this fact sheet.
The Government announced that bulk billing incentives have been doubled. This is for all telehealth services and all face-to-face services too. The items are still only able to be claimed for unreferred services and for patients with concession cards or who are under 16. The incentives have increased to $12.75 per service in major cities, and to $19.30 per service in areas outside metropolitan centres.
The announcement does not mean that the rebate for regular bulk-billed COVID-19 telehealth items has been doubled.
If you feel you and your speciality has been ignored or there are other issues with the COVID-19 telehealth items, please email firstname.lastname@example.org with your feedback so that we can follow up on your concerns.
The AMA has been informed that the bulk billing requirement will be relaxed in the near future. However, until it is formally announced, practitioners who wish to use the COVID-19 MBS telehealth items must agree to bulk bill these consults.
Providers do not need to be in their regular practice to provide telehealth services. Providers should use their provider number for their primary location and must provide safe services in accordance with normal professional standards.
While it is still preferred that a physical signature is obtained for an assignment of benefit, the rules have been relaxed for COVID-19 telehealth items only. The new guidelines state that “a practitioner’s documentation in the clinical notes of the patient’s agreement to assign their benefit as full payment for the service would be sufficient.” You can find the full details on page 5 of this FAQ.
The Department has said that a patient can assign their MBS benefit without a physical signature if they come into the practice.
With Medicare Easyclaim, a patient assigns their right to a Medicare benefit to the practitioner by pressing the OK or YES button on the EFTPOS terminal in the practice. Additionally, a patient can assign their benefit to an eligible provider by email or through the signature of a ‘responsible’ third party .
Up until 30 September 2020, a practitioner can record the agreement for assignment of benefit in the patient’s clinical notes then mark the box on the DB020 form that indicates a patient is ‘unable to sign’. The reason for a signature not being obtained can be given as ‘COVID-19/highly infectious pandemic/risk of exposure to COVID-19/etc’.
Yes, with Medicare Easyclaim, a patient assigns their right to a Medicare benefit to the practitioner by pressing the OK or YES button on the EFTPOS terminal in the practice. Additionally, a patient can assign their benefit to an eligible provider by email or through the signature of a ‘responsible’ third party .
Up until 30 September 2020, a practitioner can record the agreement for assignment of benefit in the patient’s clinical notes then mark the box on the DB020 form that indicates a patient is ‘unable to sign’. The reason for a signature not being obtained can be given as ‘COVID-19/highly infectious pandemic/risk of exposure to COVID-19/etc’.
You may use mail, email or fax for prescriptions and referrals. Doctors are also authorised to take photos of scripts, however, schedule 8 drugs are not included in this. The AMA supports the fast-tracking of e-prescribing and e-referring underway by the Department of health.
There are currently no MBS telehealth items that will allow GP nurses to provide telehealth on behalf of GPs.
Allied health professionals can provide telehealth under the Workforce Incentive Program arrangements.
The expansion of temporary MBS telehealth items in response to COVID-19 enables GPs and other practitioners to provide MBS funded services to patients in residential aged care facilities (RACFs) via video-conferencing or by telephone.
Telehealth consultations must only be provided where it is clinically safe and appropriate to do so.
Medicare rebates for the temporary telehealth items are currently only available when the service is bulk billed.
There are no specific RACF telehealth items. However, GPs or other medical practitioners will be able to claim the corresponding general MBS consultation telehealth item(s) for the service provided.
For example, a GP Level B attendance (MBS Item 23) provided to a RACF patient conducted by video-conference or telephone would attract a 91800 (video-conference) or 91809 (telephone) item.
The new temporary MBS telehealth items will have similar requirements to the normal items on which they are based. You can look up the exact detail of these items are www.mbsonline.gov.au
To see the equivalent telehealth items refer to the GPs and OMPs items Fact Sheet.
First, please make sure you and your practice are safe. The health of our medical and health workforce is a key priority for the AMA. If you are a GP, please contact your PHN for supplies. If you do not have access to the correct PPE do not treat or conduct testing on patients with potential COVID-19. Contact your local public health unit for advice on where to direct patients. If the issue is not resolved, please let us know at email@example.com.
WHAT IS THE MECHANISM FOR THE PATIENT TO ASSIGN THEIR BENEFIT TO THE PRACTITIONER FOR BULK BILLED TELEHEALTH OR TELEPHONE SERVICES?
The process for a patient to assign their benefit for a telehealth or telephone consultation is outlined here
The AMA understands that medical indemnity insurance will cover telehealth activities under practitioner cover, provided you deliver the service in accordance with relevant guidelines and observe any specific requirements for telehealth set by your Medical Defence Organisation.
If you have any specific questions, please call your indemnity provider for individual advice.
The following medical indemnity insurers have provided medico-legal advice in response to COVID-19 for doctors and practices on their website:
- SUPPORT MEASURES FROM THE FEDERAL GOVERNMENT
- AUSTRALIAN TAXATION OFFICE - TAX RELIEF
- SUPPORT PACKAGED FROM AUSTRALIAN BANKS
SUPPORT MEASURES FROM THE FEDERAL GOVERNMENT
Businesses impacted by coronavirus will be able to apply for a subsidy from the Government to continue paying their employees.
Employers can claim a fortnightly payment of $1,500 per eligible employee from 30 March for a maximum of six months.
A business is eligible if they:
- have a turnover of less than $1 billion and their turnover will be reduced by more than 30 per cent relative to a comparable period a year ago (of at least a month); or
- have a turnover of $1 billion or more and their turnover will be reduced by more than 50 per cent relative to a comparable period a year ago (of at least a month); and
- are not subject to the Major Bank Levy.
Non-for-profits (including charities) and self-employed individuals without employees that meet the turnover criteria above are eligible to apply.
Employees are eligible if they:
- are currently employed by the eligible employer (including those stood down or re-hired);
- were employed by the employer at 1 March 2020;
- are full-time, part-time, or long-term casuals (a casual employed on a regular basis for longer than 12 months as at 1 March 2020);
- are at least 16 years of age;
- are an Australian citizen, the holder of a permanent visa, a Protected Special Category Visa Holder, a non-protected Special Category Visa Holder who has been residing continually in Australia for 10 years or more, or a Special Category (Subclass 444) Visa Holder; and
- are not in receipt of a JobKeeper Payment from another employer.
Employers can register their interest in applying for the JobKeeper Payment by visiting here.
The first payment will be received by employers from the ATO in the first week of May. Payments will be backdated to 30 March.
Employers must identify employees eligible for the payment and provide monthly updates to the ATO.
Participating employers will be required to ensure eligible employees will receive, at a minimum, $1,500 per fortnight, before tax.
It will be up to the employer if they want to pay superannuation on any additional wage paid because of the JobKeeper Payment.
A fact sheet for the Job Keeper payment is available here.
Cash payments for small and medium-sized businesses
The Boosting Cash Flow for Employers payment is available to eligible small and medium-sized businesses, and not-for-profits (including charities).
Businesses can receive up to $100,000 to cover the cost of rent, bills and employee wages and salaries. Payments will be automatic.
The initial payments from 28 April will equal to 100 per cent of the salary and wages withheld as reported in Business Activity Statements. The maximum payment is $50,000 with a minimum payment of $10,000.
- Businesses are eligible if they have an aggregated annual turnover of under $50m and employ workers.
Additional payments are being introduced in July – October 2020. Businesses that are still active will receive an additional payment equal to the total of all of the Boosting Cash Flow for Employers payments received. i.e. if you received $50,000 in the first payment, you would receive a $50,000 for the second payment, for a total $100,000 payment.
Support for business asset investment
The Government has provided incentives to encourage businesses with a turnover of less than $500m to spend by:
- Increasing instant asset write-off by lifting the threshold to $150,000 (from $30,000) until June 2020.
- Introducing a time-limited 15-month incentive to invest by accelerating depreciation deductions. Businesses will be able to deduct 50 per cent of the cost of an eligible asset on installation, with existing depreciation rules applying to the balance of the asset cost.
Temporary relief for financially distressed businesses
The Government is temporarily increasing the threshold at which creditors can issue a statutory demand on a company and the time companies have to respond to statutory demands they receive.
The package also includes temporary relief for directors from any personal liability for trading while insolvent. The Corporations Act 2001will be amended to provide temporary and targeted relief for companies to deal with unforeseen events that arise as a result of the Coronavirus.
Support for lending to small and medium-sized businesses
The Coronavirus SME guarantee scheme will support lending to small and medium-sized businesses with a turnover of less than $50m.
- The commonwealth will guarantee 50 per cent of an eligible loan through participating banks and non-bank lenders to businesses disrupted by the coronavirus.
- Loans will be used for working capital purposes and be unsecured and it will be for loans granted within six months starting 1 April 2020.
- Lenders will not be charged a fee for accessing the guarantee scheme.
- Loans will be repayment-free for six months (as per the support package from Australian banks—see below).
- The maximum that can be borrowed under the guarantee facility will be $250,000 on terms up to three years.
Support packages from Australian banks
The Australian Banking Association (ABA) has announced a small business relief package to support small business during COVID-19. All ABA member banks can participate.
Broadly, the package includes a deferral of principle and interest repayment for all term loans and retail loans for 6 months, for small businesses with less than $3 million in total debt owed to credit providers. At the end of the deferral period, businesses will not be required to pay the deferred interest in a lump sum. Either the term of the loan will be extended, or the level of loan repayments will be increased.
All small businesses have been encouraged to contact their banks about the small business relief package. Fast-track approval processes are in place to ensure support is available as soon as possible.
Commonwealth Bank of Australia
- 100 bps (basis points) interest rate reduction for all existing cash-linked small business loans.
- Overdrafts will be reduced by 200bps for new and existing small business customers, effective 6 April.
- Small business customers with cash flow issues can defer principle and interest repayments of business term loans for six months.
- 100bps reduction to variable interest rates on small business cash-based loans, effective 6 April.
- Defer principle and interest for up to six months on a range of business and equipment finance loans.
- Receive a 200bps rate cut on new loans and all overdrafts on QuickBiz, effective March 30.
- Receive a further 100bps reduction on variable rates for small business loans, effective March 30.
- Access up to $65bn of additional secured limits to pre-assessed customers, with $7bn currently available for fast assessment process.
- Defer business credit card repayments.
- Decrease variable interest rates by 0.25%pa, effective 27 March.
- Enable impacted customers to request a six-month payment deferral on loan repayments for term loans, with interest capitalised.
- Make available temporary increases in overdraft facilities for 12 months.
- Institute a reduction by 0.80%pa to a new two and three-year fixed rate of 2.59%pa for secured small business loans up to $1m, effective 3 April 2020.
Australian Taxation Office – tax relief
Businesses impacted by COVID-19 are being encouraged to contact the ATO to discuss relief options tailored to their needs and circumstances.
Options available to assist businesses impacted by COVID-19 include:
- Deferring by up to six months the payment date of amounts due through the business activity statement (including Pay As You Go (PAYG) instalments), income tax assessments, fringe benefits tax assessments and excise.
- Allow businesses on a quarterly reporting cycle to opt into monthly GST reporting in order to get quicker access to GST refunds they may be entitled to.
- Allowing businesses to vary PAYG instalment amounts to zero for the March 2020 quarter. Businesses that vary their PAYG instalment to zero can also claim a refund for any instalments made for the September 2019 and December 2019 quarters.
- Remitting any interest and penalties, incurred on or after 23 January 2020, that have been applied to tax liabilities.
- Working with affected businesses to help them pay their existing and ongoing tax liabilities by allowing them to enter into low-interest payment plans.
Call the ATO Emergency Support Infoline 1800 806 218 to discuss COVID-19 support options.
MY PATIENT HAS ASKED IF THEY CAN GET A PRESCRIPTION THAT ENABLES THEM TO STOCKPILE THEIR MEDICATION – WHAT SHOULD I DO?
The Therapeutic Goods Administration (TGA) at this time has advised that stockpiling medicines is not necessary. It is essential that the public does not stockpile medicines to ensure there is equitable access for everyone. If individuals stockpile medicine, there is a risk that the unused medication will become out of date and therefore cannot be used.
Doctors have an important role to ensure their patients understand the risks of stockpiling and its impacts on the community. It is likely that doctors will receive requests from their patients to be able to receive higher quantities of medications.
Regulation 49 (previously regulation 24) prescriptions allow a PBS medication’s original and repeat to be supplied at the same time (i.e. higher quantities of medication are received by the patient in one transaction). Regulation 49 prescriptions can only be prescribed in certain circumstances, as specified by the Department of Health.
More information on Regulation 49 prescriptions is available at the Department of Health PBS website – Prescribing Medicines – Information for PBS Prescribers, here.
The AMA is calling on all members and the wider profession to ensure that only those patients who are eligible and meet the criteria are provided with Regulation 49 prescriptions
A number of restrictions on medication supply were announced on 19 March 2020 as a result of patient stockpiling and demand during the COVID-19 crisis. Details include:
Pharmacists will be required to:
- limit particular prescription products to one month’s supply (at the prescribed dose),
- limit a maximum of one unit per purchase for particular over the counter medications,
- Pharmacists are strongly encouraged to limit dispensing and sales of all other medicines to one month’s supply or one unit,
- Salbutamol inhalers will require confirmation of the patient’s diagnosis, the supply recorded and the inhaler labelled with the patient’s name,
- Paracetamol paediatric formulations will be placed behind the counter to assist in equitable supply.
A full list of the medicines, including more detail on the restrictions, are available on the TGA’s website, here.
As of 24 March 2020, there are new restrictions for prescribing hydroxychloroquine. Initial treatment of hydroxychloroquine must be authorised by a medical practitioner under the following specialties:
- Intensive care medicine
- Paediatrics and child health
- Emergency medicine
These restrictions are outlined in the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020.
More information on the restrictions, hydroxychloroquine and COVID-19, are available on the TGA website, here.
The PBS authority line has experienced an increased number of calls on 25 March 2020 which has caused an emergency message to be activated. The Department of Health is aware of the issue and are working to resolve it.
You should first contact your PHN or local hospital and health service. You can find your local PHN here.
The rural workforce agency in your state will also be able to help you. Their websites are listed here.
In a further response to the COVID-19 pandemic, the Medical Board of Australia (the Board) has agreed to a series of new measures that apply to medical practitioners the full release can be found here.
Continuing professional development (CPD)
Medical practitioners are to continue to do CPD that is relevant to their scope of practice. However, the Board will not take action if you cannot meet the CPD registration standard when you renew your medical registration this year.
Requirements for interns
The Board recognises that much education is likely to be ‘on the job’ and will, therefore, waive the usual rotation requirements for interns in 2020. The Board will accept a range of supervised clinical experience for general registration.
Registration requirements for international medical graduates (IMGs)
Streamlined change of circumstances processes for hospital-based IMGs - The Board will streamline processes to enable IMGs within hospitals with limited and provisional registration to be redeployed more easily without a formal application.
Difficulties demonstrating progression towards general or specialist registration - For 2020, the Board will not refuse to renew an IMG’s registration or refuse to re-register an IMG solely because they have not been able to sit an AMC or college examination or assessment.
Alternative approaches to demonstrating English language proficiency
The Boards and AHPRA are developing alternative approaches to demonstrating English language proficiency (due to the disruption to testing).
Return to practice for recently retired practitioners
The Board and AHPRA are working to streamline the return to work process for practitioners who have been off the Register of practitioners or who have held non-practising registration for less than three years.
The Australian Health Practitioner Regulation Agency (AHPRA), the Medical Board of Australia, the Nursing and Midwifery Board of Australia and the Pharmacy Board of Australia are establishing a short-term pandemic response sub-register for the next 12 months.
This sub-register will enable doctors, nurses, midwives and pharmacists who previously held general or specialist registration and left the Register of practitioners or moved to non-practising registration in the past three years to return to practice. Only those who were properly qualified and suitable will be returned to the register, which will operate on an opt-out basis. Further details can be found on the AHPRA website.
You do not need to contact AHPRA nor do you need to fill in any forms. AHPRA will be contacting the over 40,000 practitioners who meet the criteria to alert them that they will be added to this new sub-register.
Medical Indemnity Insurance
Retired medical practitioners returning to work for the during the COVID-19 pandemic will not lose their Run Off Cover (ROCs). The AMA has been engaging with the Commonwealth Government regarding the introduction of amended the regulations to ensure that retired doctors who return to do any type of medical service will retain their ROCS cover.
Medical practitioners will still require current indemnity insurance. The AMA expects that some medical indemnity insurers will offer products tailored to the current situation, but practitioners should contact their last medical indemnity insurer for individual advice.